ITP Control Tool (ITP-CT) Accessibility Statement

1. Commitment

Sanofi is committed to providing digital solutions that are accessible to the widest possible audience, regardless of ability, disability, race, cultural background, gender, or technological requirements.

This accessibility statement applies to ITPControl.com

2. Conformance status

The Web Content Accessibility Guidelines (WCAG) defines requirements for designers and developers to improve accessibility for people with disabilities. It defines three levels of conformance: Level A, Level AA, and Level AAA.

This website is partially conformant with WCAG 2.2 Level AA, due to the limitations described below.

3. Known limitations

Despite our best efforts to ensure the accessibility of this website, there may be some limitations. Below is a description of known limitations and potential solutions.

  • Some page content is not contained within landmark regions, which may make it harder for screen reader users to navigate and locate all content on the page.
  • Interactive controls: Some interactive areas of the website have elements that may be inaccessible by keyboard or by screen reader navigation. If you are unable to complete a form, please contact us for support.
  • Color contrast ratio: Some elements do not meet the minimum thresholds and may be challenging for some people to view and distinguish.

4. Feedback and content

Please contact us at accessibility_feedback@sanofi.com if you observe an issue not listed above. If you are unable to access any content or service, we will provide an accessible alternative or offer the content in another form.

5. Preparation of this accessibility statement

This statement was prepared July 2026.

To evaluate the current level of accessibility, the website was assessed using automated testing in Axe Monitor.

6. Formal complaints

If you have notified the website manager of an accessibility issue and you are not satisfied with our response to you, you are entitled to escalate a complaint to the applicable national authority.


This site is intended for US residents only. This site only provides information on the ITP Control Tool (ITP-CT). It is not intended to be a substitute for professional medical advice, diagnosis or treatment. Sanofi does not provide medical advice or medical service, and patients should always seek the advice of a physician or other qualified healthcare professional with any questions regarding a medical condition.